Biotage AB (publ) (BIOT.ST)
SEK 90.55
(-0.11%)
SEK 90.55
(-0.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -444 Million SEK | -49.55% |
| 2022 | -224 Million SEK | -107.41% |
| 2021 | -108 Million SEK | 31.92% |
| 2020 | -158.63 Million SEK | -406.29% |
| 2019 | 51.79 Million SEK | 177.98% |
| 2018 | -66.41 Million SEK | 61.74% |
| 2017 | -173.6 Million SEK | -35.84% |
| 2016 | -127.8 Million SEK | 4.49% |
| 2015 | -133.81 Million SEK | -48.79% |
| 2014 | -89.93 Million SEK | -36.6% |
| 2013 | -65.83 Million SEK | 53.87% |
| 2012 | -142.71 Million SEK | 28.07% |
| 2011 | -198.41 Million SEK | -14.87% |
| 2010 | -172.73 Million SEK | 52.54% |
| 2009 | -363.98 Million SEK | -40.38% |
| 2008 | -259.29 Million SEK | -734.35% |
| 2007 | 40.87 Million SEK | 29.53% |
| 2006 | 31.55 Million SEK | 1098.06% |
| 2005 | 2.63 Million SEK | -88.44% |
| 2004 | 22.78 Million SEK | 130.41% |
| 2003 | -74.9 Million SEK | -191.95% |
| 2002 | -25.65 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 122 Million SEK | 569.23% |
| 2024 Q1 | -26 Million SEK | -178.79% |
| 2024 Q3 | -220 Million SEK | -198.36% |
| 2023 Q3 | -93 Million SEK | -32.86% |
| 2023 FY | 33 Million SEK | 114.73% |
| 2023 Q4 | 33 Million SEK | 135.48% |
| 2023 Q2 | -70 Million SEK | 66.18% |
| 2023 Q1 | -207 Million SEK | 7.59% |
| 2022 Q3 | -138 Million SEK | -100.0% |
| 2022 Q4 | -224 Million SEK | -62.32% |
| 2022 Q1 | -105 Million SEK | 2.78% |
| 2022 FY | -224 Million SEK | -107.41% |
| 2022 Q2 | -69 Million SEK | 34.29% |
| 2021 Q3 | -251 Million SEK | -48.97% |
| 2021 FY | -108 Million SEK | 31.92% |
| 2021 Q1 | -191.43 Million SEK | -20.68% |
| 2021 Q2 | -168.48 Million SEK | 11.99% |
| 2021 Q4 | -108 Million SEK | 56.97% |
| 2020 Q3 | -91.89 Million SEK | -171.31% |
| 2020 Q2 | -33.87 Million SEK | -229.37% |
| 2020 FY | -158.63 Million SEK | -406.29% |
| 2020 Q1 | 26.18 Million SEK | -49.45% |
| 2020 Q4 | -158.63 Million SEK | -72.62% |
| 2019 Q2 | 174.03 Million SEK | 71.9% |
| 2019 FY | 51.79 Million SEK | 177.98% |
| 2019 Q4 | 51.79 Million SEK | -52.4% |
| 2019 Q1 | 101.24 Million SEK | 252.43% |
| 2019 Q3 | 108.82 Million SEK | -37.47% |
| 2018 Q1 | -58.94 Million SEK | 66.05% |
| 2018 Q4 | -66.41 Million SEK | -175.22% |
| 2018 FY | -66.41 Million SEK | 61.74% |
| 2018 Q3 | -24.13 Million SEK | -271.24% |
| 2018 Q2 | 14.09 Million SEK | 123.91% |
| 2017 Q1 | -151.32 Million SEK | -18.4% |
| 2017 Q4 | -173.6 Million SEK | -46.04% |
| 2017 Q3 | -118.87 Million SEK | -17.8% |
| 2017 FY | -173.6 Million SEK | -35.84% |
| 2017 Q2 | -100.91 Million SEK | 33.32% |
| 2016 Q4 | -127.8 Million SEK | -27.22% |
| 2016 Q2 | -98.66 Million SEK | 39.29% |
| 2016 Q1 | -162.5 Million SEK | -21.44% |
| 2016 FY | -127.8 Million SEK | 4.49% |
| 2016 Q3 | -100.46 Million SEK | -1.83% |
| 2015 Q4 | -133.81 Million SEK | -22.28% |
| 2015 FY | -133.81 Million SEK | -48.79% |
| 2015 Q1 | -110.59 Million SEK | -22.97% |
| 2015 Q3 | -109.43 Million SEK | -30.13% |
| 2015 Q2 | -84.09 Million SEK | 23.96% |
| 2014 Q1 | -66.23 Million SEK | -0.61% |
| 2014 Q2 | -47.06 Million SEK | 28.94% |
| 2014 Q4 | -89.93 Million SEK | -54.19% |
| 2014 FY | -89.93 Million SEK | -36.6% |
| 2014 Q3 | -58.32 Million SEK | -23.92% |
| 2013 Q2 | -82.73 Million SEK | 46.28% |
| 2013 Q3 | -80.54 Million SEK | 2.64% |
| 2013 FY | -65.83 Million SEK | 53.87% |
| 2013 Q4 | -65.83 Million SEK | 18.26% |
| 2013 Q1 | -154 Million SEK | -7.91% |
| 2012 Q4 | -142.71 Million SEK | 9.12% |
| 2012 Q1 | -179.43 Million SEK | 9.57% |
| 2012 Q2 | -158.26 Million SEK | 11.8% |
| 2012 FY | -142.71 Million SEK | 28.07% |
| 2012 Q3 | -157.03 Million SEK | 0.78% |
| 2011 Q2 | -179.74 Million SEK | 13.23% |
| 2011 FY | -198.41 Million SEK | -14.87% |
| 2011 Q3 | -181.62 Million SEK | -1.05% |
| 2011 Q4 | -198.41 Million SEK | -9.24% |
| 2011 Q1 | -207.14 Million SEK | -19.92% |
| 2010 Q4 | -172.73 Million SEK | 1.23% |
| 2010 Q3 | -174.88 Million SEK | 17.56% |
| 2010 Q2 | -212.15 Million SEK | 44.65% |
| 2010 FY | -172.73 Million SEK | 52.54% |
| 2010 Q1 | -383.28 Million SEK | -5.3% |
| 2009 Q4 | -363.98 Million SEK | 0.0% |
| 2009 FY | -363.98 Million SEK | -40.38% |
| 2008 FY | -259.29 Million SEK | -734.35% |
| 2007 FY | 40.87 Million SEK | 29.53% |
| 2006 FY | 31.55 Million SEK | 1098.06% |
| 2005 FY | 2.63 Million SEK | -88.44% |
| 2004 FY | 22.78 Million SEK | 130.41% |
| 2003 FY | -74.9 Million SEK | -191.95% |
| 2002 FY | -25.65 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.01 Billion SEK | 108.85% |
| Bonesupport Holding AB (publ) | -149.86 Million SEK | -196.263% |
| Doxa AB (publ) | -102.2 Million SEK | -334.442% |
| Elekta AB (publ) | 4.46 Billion SEK | 109.935% |
| iZafe Group AB (publ) | -2.65 Million SEK | -16598.007% |
| Ortivus AB (publ) | 4.19 Million SEK | 10691.603% |
| Ortivus AB (publ) | 4.19 Million SEK | 10691.603% |
| Q-linea AB (publ) | -61.33 Million SEK | -623.952% |
| S2Medical AB (publ) | -1.51 Million SEK | -29167.752% |
| Synsam AB (publ) | 2.67 Billion SEK | 116.611% |